HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 189,262 | $7,229,808 | 0.00% |
| Schonfeld Strategic Advisors LLC | 6,553 | $250,324 | 0.00% |
| UBS Group AG | 187,888 | $7,177,321 | 0.00% |
| Walleye Trading LLC | 21,385 | $816,907 | 0.00% |
| Lee Financial Co | 320 | $12,224 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 7,516 | $287,111 | 0.00% |
| CAPITAL FUND MANAGEMENT S.A. | 15,200 | $580,640 | 0.00% |
| PEAK6 Investments LLC | 13,000 | $496,600 | 0.00% |
| Front Row Advisors LLC | 134 | $5,119 | 0.00% |
| Park Place Capital Corp | 146 | $5,577 | 0.00% |
| AVIVA PLC | 12,930 | $493,926 | 0.00% |
| Citadel Advisors | 184,510 | $7,048,282 | 0.00% |
| Pacer Advisors, Inc. | 11,115 | $424,593 | 0.00% |
| Steward Financial Group LLC | 140 | $5 | 0.00% |
| City State Bank | 110 | $4 | 0.00% |
| REGIONS FINANCIAL CORP | 6,050 | $231,110 | 0.00% |
| Tortoise Investment Management, LLC | 300 | $11,460 | 0.00% |
| CAPITAL FUND MANAGEMENT S.A. | 14,192 | $542,134 | 0.00% |
| Bridgewater Associates | 7,062 | $269,768 | 0.00% |
| First Horizon Advisors, Inc. | 1,198 | $45,764 | 0.00% |
External links
This page lists HALOZYME THERAPEUTICS INC's shareholders in Q3 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.